openPR Logo
Press release

Anti-inflammatory skincare innovation for visible transformation | ABio Materials

11-05-2025 11:46 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABIO MATERIALS

Anti-inflammatory skincare innovation for visible

ABio Materials, is a leading company in regenerative skin solutions, focusing on next-generation bio-renewable materials, exosome-based therapies, and wrinkle reduction booster. They use high-purity patented separation and purification technologies to improve skin health, address inflammation, and promote dermal regeneration.

Celexo Exosome Skin Solutions:

1. Advanced Exosome Technology

The company uses special patented methods to extract and purify plant-based exosomes, ensuring they are highly pure and effective."

Exosomes, composed of miRNA, proteins, and lipids, bind to fibroblasts, keratinocytes, and immune cells to regulate gene expression and cellular activity.

The product is designed to be compatible and bioactive due to its ability to mimic human bilayer phospholipid structures.

2. Cica-Based Regeneration

The product is made from a customized Centella asiatica variety, grown in controlled smart farms.

This plant-derived ingredient is safe, effective, and beneficial for soothing, regenerating, and protecting the skin.

This product is effective in treating inflammatory skin conditions such as acne, rosacea, atopic dermatitis, and post-laser recovery.

3. Smart Bioformulation - Exo-Cica® Block

The process involves the combination of high-purity exosome complexes to enhance their efficacy and stability.

The product contains dual-structure hyaluronic acid, providing enhanced barrier function and hydration.

The product contains human-like collagen (Collagen I & III) that aids in dermal reconstruction and skin volume restoration.

4. Anti-Inflammatory Signaling

Phase1- focuses on inflammation control, which initiates regeneration by calming skin irritation.

Phase2- of the skincare process involves barrier restoration, which involves strengthening the skin structure, enhancing defense, and retaining moisture.

Phase3-Dermal Reconstruction stimulates collagen production and wrinkle reduction, improving elasticity, pore size, and radiance visibly.

5. Clinically Proven Results

Dermatological tests reveal significant improvements in crow's feet, pore reduction, and skin radiance within two weeks.

6. Perfect Compatibility with Equipment

This product is compatible with various aesthetic devices like Auto MTS, EBD, and Needle RF, ensuring consistent and safe results across various procedures.

If you are looking for an exosome K-beauty aesthetic treatment you can find them at ABio Materials.

Click here if you are interested in ABio Materials products.

View more: Anti-inflammatory skincare innovation for visible transformation.

South Korea

ABio Materials, is a leading company in regenerative skin solutions, focusing on next-generation bio-renewable materials, exosome-based therapies, and wrinkle reduction booster.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-inflammatory skincare innovation for visible transformation | ABio Materials here

News-ID: 4254601 • Views:

More Releases from ABIO MATERIALS

Revolutionize Your Skin with Celexo Products | ABio Materials
Revolutionize Your Skin with Celexo Products | ABio Materials
ABio Materials, a leading south korean company, is dedicated to advanced biotechnology in skincare and regenerative solutions. At the core of its innovation lies exosome skincare, which helps repair damaged cells, stimulate collagen production, and restore skin vitality. These non-invasive treatments enhance elasticity, improve tone and texture, and deliver long-lasting rejuvenation. With a focus on quality and innovation, ABio Materials ensures effective solutions that promote youthful, radiant skin and long-term
Celexo AAPE Premium Stem Cell Protein for Skin and Scalp | ABio Materials
Celexo AAPE Premium Stem Cell Protein for Skin and Scalp | ABio Materials
ABio Materials is a biotechnology leader recognized for its Korean scalp booster and advanced regenerative skincare solutions. The company specializes in human adipose-derived stem cell protein extracts, offering certified innovations for both skin and scalp care. Backed by patented technologies and clinical studies, ABio Materials develops next-generation cosmetic formulations that restore vitality, rejuvenate skin, and strengthen hair health, setting a benchmark in biocosmetics and regenerative dermatology. Key Benefits of Celexo
Revitalize Your Scalp with Celexo's Black Label Products | ABio Materials
Revitalize Your Scalp with Celexo's Black Label Products | ABio Materials
ABio Materials is a south korean biotech company specializing in regenerative skin and hair growth booster that combine stem cell culture media with plant-derived exosomes. The company ensures high-stability, preservative-free formulations produced in the nation's largest freeze-drying facility. Each vial delivers billions of exosomes enriched with growth factors, clinically validated for safety and efficacy, and trusted by healthcare providers worldwide. Celexo Black Label Skin Advantages: Premium Stem Cell Culture Media:
ABio Materials, through its brand celexo, specializes in exosome-based skincare products aimed at skin regeneration and repair. T
ABio Materials, through its brand celexo, specializes in exosome-based skincare …
ABio Materials, through its brand celexo, specializes in exosome-based skincare products aimed at skin regeneration and repair. Their offerings include exosome boosters, aftercare creams, and targeted skincare solutions that prioritize innovation and quality. With facilities in Korea and a commitment to consumer education, ABio Materials is recognized for delivering effective skincare outcomes. The following solutions will transform your skin: Exosome skin boosters are central to the company's products, aimed at

All 5 Releases


More Releases for Exosome

Spotlight on Exosome Delivery Technology - Creative Biolabs Showcased at the 202 …
On September 25, 2025, the multi-day 7th Exosome-Based Therapeutic Development Summit concluded successfully. New York, USA - October 13, 2025 - During the presentations and panel discussions, participants noted the special benefits exosomes bring-including excellent biocompatibility, low immunogenicity, and the ability to cross biological barriers-reiterating their great promise in cancer treatment, neurological disorders, and immune regulation. When compared with liposomes and traditional nanoparticles, exosomes offer greater efficiencies in carrying nucleic acids,
Emerging Trends to Reshape the Exosome Technologies Market: Creative Biolabs Lau …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Exosome Technologies Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the exosome technologies market size has seen a significant exponential growth. The market is projected to expand from $0.07 billion in 2024 to $0.09 billion in 2025, with a compound
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagno …
HTF MI recently introduced Global Exosome Therapy Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborating market size (2024-2031). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. The Major Players Covered in this Report: Sistemic Ltd Aethlon Medical, Inc. (United States), Exosome Diagnostic, Inc. (United States), Thermo Fisher Scientific, Inc. (United
Exosome Innovations Transforming Healthcare Solutions
The global exosome diagnostic and therapeutic market is witnessing remarkable growth, with its projected value reaching an astounding USD 22,609.77 million by 2034, up from USD 33.04 million in 2023. This meteoric rise represents a staggering compound annual growth rate (CAGR) of 81.03% from 2024 to 2034. As the market continues to expand, the spotlight is firmly on exosomes, small extracellular vesicles that play a significant role in a variety
Exosome Technologies Market Report 2024 - Exosome Technologies Market Size, Shar …
"The Business Research Company recently released a comprehensive report on the Global Exosome Technologies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The exosome technologies market size
Exosome technologies Market Growth Expected to See Next Level | Exosome Diagnost …
The Latest Study Published by HTF MI Research on the "Exosome technologies Market'' evaluates market size, trend and forecast to 2030. The Exosome technologies market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges as well